Unlike many dull international gatherings, the recent #MA4HealthAP conference gave participants a multitude of innovative ways to engage with their peers.
Blog posts on "WHO"
The eradication of smallpox has been a great public health success over the last 30 or 40 years or so. Smallpox was responsible for 300 million–500 million deaths during the 20th century.
Children are generally more at risk than adults when environmental threats gradually grow, or when natural disaster suddenly strikes.
When ADB recently hosted a conference on using information and communication technology (ICT) in universal health coverage, it was vital not to miss the opportunity to pin down practical steps that participants could commit to taking in their own workplace. The conference culminated in the iCTen Steps: practical next steps with both quick wins and some longer-term goals that can be adapted to specific country settings, regardless of where they are on the road to universal health coverage.
ICT can bridge the gap between existing health systems and universal health coverage, but it’s a complex process and every country has its own challenges.
Malaria can be beaten. Proof of this can be found in the fact that across the Asia Pacific region, millions of people who would have died from the disease are living healthy, productive lives. Still, malaria remains a serious threat to lives and livelihoods. Endemic in 22 countries across Asia, it is contracted by an estimated 32 million people annually and kills 47,000 of them.
I see dead people. No, I don’t mean ghosts like the ones a young Haley Joel Osment could see in the 1999 hit film The Sixth Sense. I mean actual dead bodies. I see them all the time, victims of the seemingly lawless and definitely dangerous free-for-all that is driving on Cambodia’s national roads.
The Middle East Respiratory Syndrome coronavirus, or MERS-CoV, (MERS) is keeping infectious diseases experts on alert lately, although the World Health Organization (WHO) hasn’t declared MERS a global emergency.
Much of the media attention and a substantial slice of pharmaceutical research funding focuses on the fight against HIV/AIDS and other high profile infectious diseases.
The current H7N9 avian influenza (bird flu) that has infected 108 cases and claimed 22 lives, and that has just spread outside People’s Republic of China (PRC) as of 24 April 2013 should be a stern reminder that global (and regional) health threats continue to loom large.